Michael F. DeMichele just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Michael F. DeMichele claims to own 2,427,677 shares. This represents 7.15% of Cyclerion Therapeutics, Inc..
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Cyclerion Therapeutics, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 7.01 and 9.01
- Sept. 30, 2021